
Famvir250 mg
SANDOZ (A Novartis Division)
Famciclovir is an antiviral medicine indicated for the treatment and management of specific herpesvirus infections.
Famciclovir is an antiviral medicine indicated for the treatment and management of specific herpesvirus infections. Indications are classified below by strength of evidence.
Famciclovir is sometimes used off-label for varicella (chickenpox) in select adult patients and for herpes simplex prophylaxis in certain immunocompromised settings, based on clinician judgment; this is not an FDA-approved use and should only be undertaken under specialist supervision.
Dosage of Famciclovir is individualized according to the indication being treated. The table below summarizes standard adult dosing in patients with normal renal function.
| Indication | Adult Dose | Duration |
|---|---|---|
| Herpes zoster (shingles) | 500 mg every 8 hours | 7 days |
| Genital herpes, initial episode | 250 mg three times daily | 7–10 days |
| Genital herpes, recurrent episode | 1000 mg twice daily | 1 day |
| Genital herpes, suppressive therapy | 250 mg twice daily | Up to 1 year, per physician review |
| Recurrent orolabial/genital herpes in HIV-infected patients | 500 mg twice daily | 7 days |
| Herpes labialis (cold sores) | 1500 mg as a single dose | Single day |
Renal impairment: Dose and/or dosing interval must be reduced according to creatinine clearance; see Use in Special Populations. Famciclovir should be started as early as possible after the onset of symptoms (e.g., within 48–72 hours of rash or lesion onset) for best effect.
Famciclovir may be taken with or without food. Tablets should be swallowed whole with water; complete the full course as directed by the physician and do not stop, extend, skip doses, or share this medicine with others without medical advice.
Patients should seek prompt medical attention if signs of a severe allergic reaction or unusual neurological symptoms occur while taking Famciclovir.
Famciclovir is contraindicated in patients with known hypersensitivity to Famciclovir, penciclovir, or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.